Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Chronic Aphasia



Status:Recruiting
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - 80
Updated:4/6/2019
Start Date:March 28, 2019
End Date:June 30, 2023
Contact:Samuel Cason, MA
Email:samuel.cason@pennmedicine.upenn.edu
Phone:215-573-4336

Use our guide to learn which trials are right for you!

A Phase II, Randomized Blinded Study of the Effects of Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for the Treatment of Chronic Aphasia

Transcranial Magnetic Stimulation (TMS) has been demonstrated to improve language function in
subjects with chronic aphasia in a number of small studies, many of which did not include a
control group. Although the treatment appears promising, data to date do not permit an
adequate assessment of the utility of the technique. The investigators propose to study the
effects of TMS combined with Constraint Induced Language Therapy (CILT) in 75 subjects with
chronic aphasia. Subjects will be randomized in a 2:1 ratio to TMS with CILT or sham TMS with
CILT. One Hz TMS at 90% motor threshold will be delivered to the right inferior frontal gyrus
for 20 minutes in 10 sessions over 2 weeks; language therapy will be provided for one hour
immediately after the conclusion of each session of TMS. Change from baseline in the Western
Aphasia Battery Aphasia Quotient at 6 months after the end of TMS treatment will serve as the
primary outcome measure. A secondary aim is to identify anatomic and behavioral predictors of
response to treatment. Finally, a third aim is to identify the mechanism underlying the
beneficial effect of the treatment using a variety of imaging techniques. Subjects who have
no contraindication to the MRI will undergo fMRI imaging prior to and at 6 months after
therapy. Using modern network analyses and robust machine learning techniques, the
investigators will identify changes in the strengths of connections between nodes in the
language network to address specific hypotheses regarding the effects of TMS and CILT on
brain organization that are associated with beneficial response to treatment.

TMS is a technique by which a brief electrical current is induced in brain tissue causing a
brief suppression of the excitability of the underlying tissue; the technique, which was
introduced in the 1980s and has been extensively used around the world, has been shown to
transiently improve or disrupt specific cognitive operations. To achieve this end, a coil is
positioned against the subject's head. The delivery of a single pulse begins with the
discharge of current from a capacitor into a circular or figure-of-eight coil; this
electrical current generates a brief magnetic field of up to 2.2 Tesla. As the pulse of
electricity has a rise time of 0.2 ms. and a duration of 1 ms., the magnetic field changes in
intensity quite rapidly. Because the magnetic field passes freely through the scalp, skull,
and meninges, the flux in the magnetic field induces a small electric field in the brain that
transiently alters neural activity.

TMS may be delivered in a variety of ways. The investigators propose to use 1 Hz TMS; that
is, TMS pulses will be delivered at a frequency of 1/second. This style of TMS is assumed to
be inhibitory in that it transiently suppresses the function of the cortex under the coil.
Using the figure-of-eight coil to be employed here, TMS is thought to reduce activity in
approximately 1 cubic cm. of cortex. Many investigators have employed TMS with a frequency of
1 Hz for periods of 20 minutes and longer; mild behavioral deficits are often present for
several minutes in these studies.

The baseline phase will consist of 3 sessions, each lasting 1-2 hours depending on the
stamina of the subject. The point of the baseline testing is to characterize the subject's
language function. To that end, a number of standard language and neuropsychological tasks
will be administered. These include the Western Aphasia Battery, Pyramids and Palm Trees
test, Figural Fluency Test, word and non-word repetition tasks, the Nicholas and Brookshire
Narratives, CILT stimulus naming, and Northwestern Assessment of Verbs and Sentences.
Additionally, during the baseline, subjects will undergo MRI of the brain or, if they have a
contraindication to MRI, a CAT scan of the head. No contrast will be used.

In the treatment phase, there will be 10 TMS sessions over 2 consecutive weeks in which 20
minutes (1200 pulses) of 1 Hz TMS at 90% motor threshold will be delivered to the inferior
pars triangularis. Each TMS treatment session will be immediately followed by a 60-90 minute
session of CILT

There will be two 3-month post-treatment visits and two 6-month post-treatment visits in
which the full battery of language and cognitive assessments will be repeated. Subjects who
are able to undergo MRI scanning will have anatomic and fMRI scans at the first 6-month
post-treatment visit.

The investigators will pair TMS with CILT which has been shown to have positive outcomes in
post-stroke aphasia. CILT invokes use-dependent learning in communicative interactions by
requiring spoken output and restricting use of alternative forms of communication, such as
gestures. The investigators will use a dual card-matching task modeled after Maher et al. As
in the original CILT design, the participant interacts verbally with a conversational partner
(here, the speech language pathologist), in turn requesting a card of given description and
complying with the partner's request. In this way, the treatment targets both production and
comprehension. Moreover, as verbal targets increase in linguistic complexity across the
protocol ("a ball", "throw a ball"; "Do you have a ball"?), a variety of lexical and phrasal
structures are targeted. Studies of CILT have reported gains on multiple language behaviors,
supporting its broad engagement of the language network.

Inclusion Criteria:

- Clinical evidence and MRI or CT verification of a single left hemisphere stroke with
moderate to severe aphasia.

- Suffered their stroke at least 6 months prior to their testing

- Must be able to understand the nature of the study, and give informed consent

Exclusion Criteria:

- Multiple strokes (excluding small lacunar strokes) as defined by brain imaging

- History of substance abuse

- Previous head trauma with loss of consciousness for more than 5 minutes

- Psychiatric illness (We note that subjects will be assessed with the 15-item Geriatric
Depression scale. Because depression is very difficult to evaluate in aphasic
subjects, potential subjects will not be excluded on the basis of the depression
score)

- Chronic exposure to medications that might be expected to have lasting consequences
for the central nervous system (e.g. haloperidol, dopaminergics)

- History of or neuropsychological findings suggestive of dementia
We found this trial at
1
site
3451 Walnut St
Philadelphia, Pennsylvania 19104
1 (215) 898-5000
Principal Investigator: H B Coslett, MD
Phone: 215-573-4336
Univ of Pennsylvania Penn has a long and proud tradition of intellectual rigor and pursuit...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials